Alimera Sciences Inc (ALIM)

1.45
NASDAQ : Health Care
Prev Close 1.58
Day Low/High 1.42 / 1.59
52 Wk Low/High 1.01 / 2.40
Avg Volume 354.30K
Exchange NASDAQ
Shares Outstanding 64.90M
Market Cap 102.54M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Alimera Sciences To Expand ILUVIEN® Indication In Europe For Posterior Uveitis

Alimera Sciences To Expand ILUVIEN® Indication In Europe For Posterior Uveitis

Signs license agreement with pSivida for posterior uveitis in Europe, the Middle East and Africa

Alimera Sciences Announces The Reimbursement Of ILUVIEN® In Italy

ILUVIEN is fully reimbursable as a hospital-administered therapy in Italy

Alimera Sciences Begins Selling ILUVIEN® In The Middle East

Alimera Sciences Begins Selling ILUVIEN® In The Middle East

First DME patient in the region has received treatment

First Week of November 18th Options Trading For Alimera Sciences (ALIM)

First Week of November 18th Options Trading For Alimera Sciences (ALIM)

Investors in Alimera Sciences, Inc. saw new options become available this week, for the November 18th expiration.

April 2017 Options Now Available For Alimera Sciences (ALIM)

April 2017 Options Now Available For Alimera Sciences (ALIM)

Investors in Alimera Sciences, Inc. saw new options become available today, for the April 2017 expiration.

Alimera (ALIM) Is Today's Strong On High Volume Stock

Alimera (ALIM) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Alimera (ALIM) as a strong on high relative volume candidate

Weak On High Volume: Alimera (ALIM)

Weak On High Volume: Alimera (ALIM)

Trade-Ideas LLC identified Alimera (ALIM) as a weak on high relative volume candidate